True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations—Brief Report

Donor cell leukemia (DCL) is a rare complication after allogeneic hematopoietic stem cell transplantation (HSCT) accounting for 0.1% of relapses and presenting as secondary leukemia of donor origin. Distinct in phenotype and cytogenetics from the original leukemia, DCL’s clinical challenge lies in i...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Michèle Hoffmann, Yara Banz, Jörg Halter, Jacqueline Schoumans, Joëlle Tchinda, Ulrike Bacher, Thomas Pabst
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2024-04-01
Serie:	Current Oncology
Soggetti:	donor cell leukemia allogeneic hematopoietic stem cell transplantation mixed-phenotype acute leukemia chimerism leukemogenesis
Accesso online:	https://www.mdpi.com/1718-7729/31/4/153
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!